Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Clinical trial NCT02146066 · AVAILABLE
Trial details
- NCT number
- NCT02146066
- Sponsor
- Northwest Biotherapeutics
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.